Contepo offers a unique mechanism of action and has the potential to address increasing antibiotic resistance and gaps in the current antibiotic treatment landscape
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
The pooled prevalence of GERD in the Indian population is 15.6 %
Lupin can receive a potential total consideration of up to USD 84 million based on future contingent milestones
Vonoprazan is a potassium-competitive acid blocker (P-CAB) used for the treatment of acid-related disorders
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
Acquisition provides Ligand with the royalty rights to QARZIBA, a highly differentiated, commercial oncology drug marketed in 35 countries by global pharmaceutical company Recordati S.p.A.
Olverembatinib, a novel drug developed by Ascentage Pharma with support from the National Major New Drug Development program
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
